Our CSO, Sareina Wu, PhD was invited to speak at the RASUS Global events: Next Generation Cell & Gene Therapy conference.

She spoke about GenomeFrontier’s latest technology breakthroughs, including the advancement of CAR-T cell therapy using qCART™, a virus-free Quantum Engine™, for development and production of multiplex CAR-T cell therapy.